Koch Thomas, Brandenburg Lars-Ove, Liang Yingjian, Schulz Stefan, Beyer Andrea, Schröder Helmut, Höllt Volker
Department of Pharmacology and Toxicology, Otto-von-Guericke University, Magdeburg, Germany.
J Neurochem. 2004 Feb;88(3):680-8. doi: 10.1046/j.1471-4159.2003.02189.x.
Receptor phosphorylation, arrestin binding, uncoupling from G protein and subsequent endocytosis have been implicated in G protein-coupled receptor desensitization after chronic agonist exposure. In search of proteins regulating the mu-opioid receptor endocytosis, we have recently established that activation of phospholipase D (PLD)2 is required for agonist-induced mu-opioid receptor endocytosis. In this study, we determined the effect of PLD2 activity on the desensitization and resensitization rate of the mu-opioid receptor. We clearly demonstrated that inhibition of PLD2-mediated phosphatidic acid formation by alcohol (1-butanol or ethanol) or overexpression of a dominant negative mutant of PLD2 prevented agonist-mediated endocytosis and resulted in a faster desensitization rate of the mu-opioid receptor after chronic (D-Ala2, Me Phe4, Glyol5)enkephalin treatment in human embryonic kidney 293 cells. Moreover, inhibition of PLD2 activity led to an impairment of the resensitization rate of the mu-opioid receptor. In summary, our data strongly suggest that PLD2 is a modulator of agonist-induced endocytosis, desensitization and resensitization of the mu-opioid receptor.
受体磷酸化、与阻遏蛋白结合、与G蛋白解偶联以及随后的内吞作用都与慢性激动剂暴露后的G蛋白偶联受体脱敏有关。为了寻找调节μ-阿片受体内吞作用的蛋白质,我们最近证实,激动剂诱导的μ-阿片受体内吞作用需要磷脂酶D(PLD)2的激活。在本研究中,我们确定了PLD2活性对μ-阿片受体脱敏和再敏化速率的影响。我们清楚地证明,用酒精(1-丁醇或乙醇)抑制PLD2介导的磷脂酸形成或过表达PLD2的显性负突变体可阻止激动剂介导的内吞作用,并导致人胚肾293细胞在慢性(D-Ala2,Me Phe4,Glyol5)脑啡肽处理后μ-阿片受体的脱敏速率加快。此外,抑制PLD2活性会导致μ-阿片受体再敏化速率受损。总之,我们的数据强烈表明PLD2是激动剂诱导的μ-阿片受体内吞作用、脱敏和再敏化的调节剂。